Gujarat Kidney and Super Speciality IPO Oversubscribed 5.21 Times on Final Day
Gujarat Kidney and Super Speciality's ₹251-crore IPO achieved 5.21 times overall subscription on the final bidding day, with retail investors leading at 19.04 times subscription. The healthcare company raised over ₹100 crore from anchor investors and will use proceeds for hospital acquisitions, new facility setup, equipment purchase, and debt repayment. Shares are set to list on BSE and NSE with expectations of stable to positive debut.
*this image is generated using AI for illustrative purposes only.
Gujarat Kidney and Super Speciality's initial public offering concluded with robust investor interest, achieving 5.21 times overall subscription on the final day of bidding. The strong response reflects growing investor confidence in the regional healthcare sector.
Subscription Details
The ₹251-crore IPO witnessed varied participation across investor categories, with retail investors driving the strongest demand.
| Category | Subscription Multiple |
|---|---|
| Overall Subscription | 5.21x |
| Retail Investors | 19.04x |
| Non-Institutional Investors (NIIs) | 5.73x |
| Qualified Institutional Buyers (QIBs) | 1.06x |
The retail segment's overwhelming response at 19.04 times subscription significantly outpaced other categories, while qualified institutional buyers showed relatively subdued interest at 1.06 times subscription.
Issue Structure and Pricing
The public offering was priced in the band of ₹108 to ₹114 per share, comprising entirely of a fresh issue of up to 2.20 crore equity shares. At the upper end of the price band, the issue size stands at ₹250.80 crore. Nirbhay Capital Services served as the book-running lead manager for the public issue.
Prior to the public offering, Gujarat Kidney and Super Speciality successfully mobilised over ₹100 crore from anchor investors, providing additional validation for the issue.
Fund Utilisation Plans
The company has outlined comprehensive expansion and consolidation initiatives for the IPO proceeds:
| Purpose | Details |
|---|---|
| Hospital Acquisition | Proposed acquisition of Parekhs Hospital in Ahmedabad |
| Existing Acquisition | Part-payment for already acquired Ashwini Medical Centre |
| New Facility | Setting up new hospital in Vadodara |
| Equipment Purchase | Robotics equipment for Vadodara facility |
| Debt Repayment | Repaying portion of existing debt |
| Inorganic Growth | Supporting potential unidentified acquisitions |
| General Expenses | Meeting general corporate expenses |
Company Profile and Listing
Gujarat Kidney and Super Speciality operates as a regional healthcare company with primary operations in central Gujarat. The company's shares are proposed to be listed on both the BSE and NSE in the following week.
Given the strong retail and non-institutional participation, market participants expect a stable to positive listing, though overall performance will depend on broader market conditions at the time of debut.
20
